BioISI researchers from the Biomedical and Translational Group developed a survey on personalized prevention in health.
A group of researchers from the Biomedical and Translation Group at the National Institute of Health Dr. Ricardo Jorge (INSA) developed a survey on the barriers, challenges and facilitators regarding the use of personalized prevention in health, in collaboration with the Università Cattolica del Sacro Cuore of Italy and the Karolinska Institute of Sweden, Within the PROPHET project – dedicated to the personalized prevention of chronic diseases in the European Union (EU).
This survey is targeted to health professionals, researchers and policy makers, but also at all citizens interested in the topic, and aims to contribute to the advancement of research and implementation of personalized prevention strategies in the EU. Personalized prevention aims to prevent the onset, progression and recurrence of the disease, through the adoption of targeted interventions that consider biological information, the environment, behavior as well as the socioeconomic and cultural context of individuals. These interventions must also be timely, effective and equitable to maintain the best possible state of health throughout life.
Funded by the European Commission’s Horizon Europe programme, PROPHET aims to support the definition and implementation of innovative, sustainable and high-quality personalized prevention strategies that effectively prevent chronic diseases such as cancer or cardiovascular disease. In addition to the UK, it involves 18 partners from 12 different EU member states, including Portugal, through BioISI – INSA.
On behalf of the project team, we kindly ask you to fill in this survey since you will be contributing to the definition and implementation of personalized prevention strategies for chronic diseases such as cancer or cardiovascular diseases, in the EU.
Access the survey here.
More about the PROPHET project here.
Know more about personalized prevention here.